# Northwest Biotherapeutics Inc: Form 8-K, filed Nov 1, 2024

- Company: [Northwest Biotherapeutics Inc](/companies/nwbo.md) (CIK 1072379)
- Form: 8-K
- Filed: 2024-11-01
- Accepted by EDGAR: Nov 1, 2024, 17:24 ET
- Period: 2024-10-31
- Accession: 0001104659-24-113553
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1072379/000110465924113553/tm2420750d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1072379/000110465924113553/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1072379/000110465924113553/tm2420750d1_8k.htm

Filed Nov 1, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-113553. Last ingested by Listed: Oct 30, 2026, 16:18 ET. No prices; not investment advice.